JP2024539631A5 - - Google Patents
Info
- Publication number
- JP2024539631A5 JP2024539631A5 JP2024522235A JP2024522235A JP2024539631A5 JP 2024539631 A5 JP2024539631 A5 JP 2024539631A5 JP 2024522235 A JP2024522235 A JP 2024522235A JP 2024522235 A JP2024522235 A JP 2024522235A JP 2024539631 A5 JP2024539631 A5 JP 2024539631A5
- Authority
- JP
- Japan
- Prior art keywords
- approximately
- degrees
- angstroms
- angstrom
- crystalline form
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163255562P | 2021-10-14 | 2021-10-14 | |
| US63/255,562 | 2021-10-14 | ||
| PCT/US2022/078143 WO2023064920A1 (en) | 2021-10-14 | 2022-10-14 | Crystalline forms of a substituted benzimidazole acting as as cdk9 inhibitor and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024539631A JP2024539631A (ja) | 2024-10-29 |
| JP2024539631A5 true JP2024539631A5 (enExample) | 2025-10-23 |
Family
ID=84272325
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024522235A Pending JP2024539631A (ja) | 2021-10-14 | 2022-10-14 | Ｃｄｋ９阻害剤として作用する置換ベンズイミダゾールの結晶形態およびその使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20250011298A1 (enExample) |
| EP (1) | EP4416139A1 (enExample) |
| JP (1) | JP2024539631A (enExample) |
| KR (1) | KR20240115816A (enExample) |
| CN (1) | CN118355006A (enExample) |
| AU (1) | AU2022362075A1 (enExample) |
| CA (1) | CA3234907A1 (enExample) |
| IL (1) | IL312030A (enExample) |
| MX (1) | MX2024004515A (enExample) |
| WO (1) | WO2023064920A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20220079851A (ko) * | 2019-09-11 | 2022-06-14 | 프렐루드 테라퓨틱스, 인코포레이티드 | Cdk 억제제 및 약제로서의 이의 용도 |
| WO2025076115A1 (en) * | 2023-10-02 | 2025-04-10 | Prelude Therapeutics Incorporated | Cdk inhibitors and their use as pharmaceuticals |
| WO2025189114A1 (en) | 2024-03-08 | 2025-09-12 | Prelude Therapeutics Incorporated | Cdk inhibitors and their use as pharmaceuticals |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20220079851A (ko) | 2019-09-11 | 2022-06-14 | 프렐루드 테라퓨틱스, 인코포레이티드 | Cdk 억제제 및 약제로서의 이의 용도 |
-
2022
- 2022-10-14 KR KR1020247015784A patent/KR20240115816A/ko active Pending
- 2022-10-14 AU AU2022362075A patent/AU2022362075A1/en active Pending
- 2022-10-14 MX MX2024004515A patent/MX2024004515A/es unknown
- 2022-10-14 IL IL312030A patent/IL312030A/en unknown
- 2022-10-14 WO PCT/US2022/078143 patent/WO2023064920A1/en not_active Ceased
- 2022-10-14 EP EP22802453.5A patent/EP4416139A1/en not_active Withdrawn
- 2022-10-14 US US18/700,928 patent/US20250011298A1/en active Pending
- 2022-10-14 CA CA3234907A patent/CA3234907A1/en active Pending
- 2022-10-14 CN CN202280081352.7A patent/CN118355006A/zh active Pending
- 2022-10-14 JP JP2024522235A patent/JP2024539631A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024539631A5 (enExample) | ||
| CA2632283C (en) | Polymorphs of a c-met/hgfr inhibitor | |
| US20100240720A1 (en) | Allosteric jnk inhibitors | |
| JP2024534014A5 (enExample) | ||
| EP2875006B1 (en) | Acid ceramidase inhibitors and their use as medicaments | |
| WO2003103655A1 (ja) | 癌治療剤 | |
| EP1738752A1 (en) | Pharmaceutical combinations comprising cis-retine acid | |
| JP2020509062A (ja) | ２−（置換フェニルヘテロ）芳香族カルボン酸系ｆｔｏ阻害剤、その製造方法およびその使用 | |
| US11155537B2 (en) | Crystal of benzofuran derivative free base and preparation method | |
| JP2024518429A5 (enExample) | ||
| US11130740B2 (en) | Substituted 2,3-dihydro-1H-indene analogs and methods using same | |
| WO2014108066A1 (zh) | 氨基康普立停衍生物的合成及其作为口服抗肿瘤药物的应用 | |
| JP2025504791A (ja) | ヒドロキシフェニル部分を含む化合物及びその使用 | |
| JP4238334B2 (ja) | 細胞増殖抑制性ヒドロキサム酸誘導体 | |
| US11186549B2 (en) | Therapeutic indazoles | |
| US9353146B2 (en) | Acylation derivatives of paridis saponins I, preparation method therefor and application thereof | |
| CA3091642A1 (en) | Agents and methods for treating dysproliferative diseases | |
| JP7840959B2 (ja) | シクロペンテノン誘導体及び抗生物質としてのその使用 | |
| CN118834152A (zh) | 一种维拉佐酮衍生物v02及其合成方法和在制备抗肿瘤药物中的应用 | |
| CN101448833A (zh) | 5-氯-6-(2,6-二氟-4-[3-(甲基氨基)丙氧基]苯基)-N-[(1S)-2,2,2-三氟-1-甲基乙基][1,2,4]三唑并[1,5-a]嘧啶-7-胺盐的晶形 | |
| EP3596054B1 (en) | 5-carboxamide-2-thiobarbituric acids and use thereof as medicaments | |
| CN107129465B (zh) | 芳基胍类化合物及其制备方法和用途 | |
| CN115724784A (zh) | 作为p53调节剂和/或hdac抑制剂的化合物 | |
| CS63691A2 (en) | 1-alkyl-,1-alkenyl/and 1-alkinylaryl-2-amino-1,3-propandiols and relatedcompounds, method and intermediates for their preparation and their application as drugs | |
| KR102501514B1 (ko) | 2'-아미노-6-(2-아미노-6-(1-이소프로필피페리딘-4-일)-5-메틸피리미딘-4-일)-3'-플루오로-[2,4'-바이피리딘]-5-올 3염산염 및 이를 포함하는 약제학적 조성물 |